Skip to content
May 23, 2024

Equity.Guru

Investment information for the new generation

Search

Search Results for: FH.NE

In this summary report, we will take a quick look at the top 5 gainers and losers up or down double digits on the Canadian stock markets. Here is…
In this summary report, we will take a quick look at the top 5 gainers and losers up or down double digits on the Canadian stock markets. Here is…
Filament Health (FH.NEO), a Vancouver, British Columbia-based clinical stage natural psychedelic drug development company, announced today that it had been issued its 8th patent for the extraction and standardization…
Filament Health (FH.E) inked a supply deal with Optimi Health (OPTI.C) for psilocybin mushrooms for testing and analysis by Filament’s research team. These mushrooms come at the behest of…
Our Psychedelic Trip Isn’t Over   I don’t know the first thing about psychedelics. Rather, that’s what I would have been saying back in 2020 when the psychedelics sector…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
It has been awhile since I talked about Filament Health and the psychedelics sector in general. In my last post, I left readers in suspense as I shared a…
Counting to Four $25.537M Market Capitalization  Filament Health Corp. (FH.NE) announced today that it has been issued a fourth patent for the extraction and standardization of natural psilocybin and…
Natural Psychedelics Revolution $21.418M Market Capitalization Filament Health Corp. (FH.NE) announced today that it has entered into an exclusive licensing agreement with Psyence Group Inc. (PSYG.C). Under the terms…
Patent Issuance $18.123M Market Capitalization Filament Health Corp. (FH.NE) announced today that it has been issued a patent by the United States Patent and Trademark Office (USPTO) for the…